fbpx

News & Press


FDA Approves Opdivo for Advanced Melanoma

December 22, 2014

Statement from Tim Turnham, Executive Director Melanoma Research Foundation   Today the FDA approved Opdivo (nivolumab), a new treatment for advanced melanoma, the deadliest form of skin cancer. This approval is a promising development for people …



A Global Effort Against Melanoma

December 19, 2014

In November, the MRF convened an international group of melanoma patient advocates with the goal of advancing the global fight against this disease. Three years ago a pharmaceutical company asked me to attend a meeting with other patient advocates from …



Congressional Committee and the Melanoma Research Foundation Take Steps to Stop College Tanning

December 18, 2014

WASHINGTON, D.C.—Today the House Committee on Energy and Commerce issued a letter, drafted by Congressman Henry Waxman (D-CA) and signed by Representatives Frank Pallone (D-NJ), Carolyn Maloney (D-NY), Rosa DeLauro (D-CT) and Charles Dent (R-PA), …



President Signs Bill Increasing Dept. of Defense’s Cancer Research Funding

December 17, 2014

Statement from Tim Turnham, Executive Director, Melanoma Research Foundation, Regarding Increase in Dept. of Defense's Cancer Research Funding President Barack Obama on Tuesday signed the $1.1 trillion spending bill that lifted the threat of a gove …



Joint Committee Files Bill to Increase Funding for Rare Cancers

December 11, 2014

WASHINGTON, D.C. — This week, a bi-partisan joint Congressional Committee filed their final version of the Fiscal 2015 Omnibus Appropriations bill that includes $50 million for the Department of Defense’s Peer Reviewed Cancer Research Progr …